SPARCL1 DEREGULATED IN ENDOMETRIOSIS LESIONS

被引：1
|
作者：
Ferriani, R. A. [1 ]
Meola, J. [1 ]
Hidalgo, G. dos S. [1 ]
Rosa e Silva, J. C. [1 ]
Paz, C. C. P. [1 ]
机构：
[1] Univ Sao Paulo, Sao Paulo, Brazil
来源：
FERTILITY AND STERILITY | 2010年 / 94卷 / 04期
关键词：
D O I：
10.1016/j.fertnstert.2010.07.789
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：S203 / S204
页数：2
相关论文
共 50 条
  • [1] SPARCL1 suppresses metastasis in prostate cancer
    Xiang, Yuzhu
    Qiu, Qingchao
    Jiang, Ming
    Jin, Renjie
    Lehmann, Brian D.
    Strand, Douglas W.
    Jovanovic, Bojana
    DeGraff, David J.
    Zheng, Yi
    Yousif, Dina A.
    Simmons, Christine Q.
    Case, Thomas C.
    Yi, Jia
    Cates, Justin M.
    Virostko, John
    He, Xiusheng
    Jin, Xunbo
    Hayward, Simon W.
    Matusik, Robert J.
    George, Alfred L., Jr.
    Yi, Yajun
    MOLECULAR ONCOLOGY, 2013, 7 (06) : 1019 - 1030
  • [2] Assessment of MMP14, CAV2, CLU and SPARCL1 expression profiles in endometriosis
    Pant, Anuja
    Dakal, Tikam Chand
    Moar, Kareena
    Dhabhai, Bhanupriya
    Arora, Taruna K.
    Sharma, Narendra Kumar
    Ranga, Vipin
    Maurya, Pawan Kumar
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 251
  • [3] The oncogenic functions of SPARCL1 in bladder cancer
    Li, Changjiu
    Yuan, Hui
    Chen, Jun
    Shang, Kun
    He, Huadong
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (22)
  • [4] SPARCL1 a novel player in cancer biology
    Gagliardi, Filippo
    Narayanan, Ashwin
    Mortini, Pietro
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 109 : 63 - 68
  • [5] SPARCL1 is an angiocrine inhibitor of tumorigenesis in colorectal carcinoma
    Tenkerian, Clara
    Regensburger, Daniela
    Langer, Victoria
    Klingler, Anika
    Borau, Anne
    Sticht, Heinrich
    Ramming, Andreas
    Wohlfahrt, Thomas
    Schmid, Benjamin
    Meniel, Valerie
    Gruetzmann, Robert
    Britzen-Laurent, Nathalie
    Schellerer, Vera
    Stuerzl, Michael
    Naschberger, Elisabeth
    CANCER RESEARCH, 2019, 79 (13)
  • [6] SPARCL1 sparkles new insight into corneal dystrophies
    Turunen, Joni A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 (12) : 1524 - 1525
  • [7] Prognostic value of SPARCL1 in patients with colorectal cancer
    Han, Wei
    Cao, Fang
    Ding, Wei
    Gao, Xiao-Jiao
    Chen, Fang
    Hu, Yong-Wei
    Ding, Hou-Zhong
    ONCOLOGY LETTERS, 2018, 15 (02) : 1429 - 1434
  • [8] Effects of SPARCL1 on the proliferation and differentiation of sheep preadipocytes
    Xiao, Cheng
    Jin, Hai Guo
    Zhang, Li Chun
    Liu, Jian Qiang
    He, Ming
    Ma, Hui Hai
    Yu, Yong Sheng
    Cao, Yang
    ADIPOCYTE, 2021, 10 (01) : 658 - 669
  • [9] Mutations in Hevin/Sparcl1 and risk of autism spectrum disorder
    Taketomi, Takumi
    Tsuruta, Fuminori
    NEURAL REGENERATION RESEARCH, 2023, 18 (07) : 1499 - 1500
  • [10] Associations of tumor suppressor SPARCL1 with cancer progression and prognosis
    Li, Ting
    liu, Xia
    Yang, Antai
    Fu, Wenjie
    Yin, Fuqiang
    Zeng, Xiaoyun
    ONCOLOGY LETTERS, 2017, 14 (03) : 2603 - 2610
12345